The Enterprise Value as of December 2024 (TTM) for Wave Life Sciences Ltd. (WVE) is 1.79B

According to Wave Life Sciences Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.79B. This represents a change of 198.87% compared to the average of 599.61M of the last 4 quarters.

Wave Life Sciences Ltd. (WVE) Historical Enterprise Value (quarterly & annually)

How has WVE Enterprise Value performed in the past?

The mean historical Enterprise Value of Wave Life Sciences Ltd. over the last ten years is 385.27M. The current 1.79B Enterprise Value has changed 46.41% with respect to the historical average. Over the past ten years (40 quarters), WVE's Enterprise Value was at its highest in in the December 2018 quarter at 1.21B. The Enterprise Value was at its lowest in in the December 2021 quarter at 58.35M.

Wave Life Sciences Ltd. (WVE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Wave Life Sciences Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Wave Life Sciences Ltd. (WVE) Average Enterprise Value

How has WVE Enterprise Value performed in the past?

The current Enterprise Value of Wave Life Sciences Ltd. (WVE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Wave Life Sciences Ltd. (WVE) Enterprise Value vs. Peers

How is WVE’s Enterprise Value compared to its peers?

Wave Life Sciences Ltd.’s Enterprise Value is less than Arrowhead Pharmaceuticals, Inc. (2.86B), greater than CytomX Therapeutics, Inc. (55.71M), greater than Assembly Biosciences, Inc. (68.78M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than VectivBio Holding AG (848.58M), greater than Icosavax, Inc. (713.87M), less than Apellis Pharmaceuticals, Inc. (4.22B), greater than iTeos Therapeutics, Inc. (148.48M), greater than TScan Therapeutics, Inc. (115.75M), greater than ProQR Therapeutics N.V. (190.45M), less than Alnylam Pharmaceuticals, Inc. (30.90B), less than Blueprint Medicines Corporation (6.04B), greater than Terns Pharmaceuticals, Inc. (221.27M), greater than Amylyx Pharmaceuticals, Inc. (211.43M), greater than Acumen Pharmaceuticals, Inc. (104.35M), greater than Inozyme Pharma, Inc. (207.87M), greater than X4 Pharmaceuticals, Inc. (89.16M), greater than Day One Biopharmaceuticals, Inc. (849.50M), greater than Mereo BioPharma Group plc (432.78M),

Build a custom stock screener for Wave Life Sciences Ltd. (WVE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wave Life Sciences Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Wave Life Sciences Ltd. (WVE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Wave Life Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.